Impact of 13-valent pneumococcal conjugate polysaccharide vaccination on severe exacerbations in patients with chronic obstructive pulmonary disease and established cardiovascular disease

Eur J Intern Med. 2019 May:63:e14-e16. doi: 10.1016/j.ejim.2019.03.010. Epub 2019 Mar 21.
No abstract available

Keywords: COPD; Cardiovascular disease; Exacerbation; Phenotype; Pneumococcal conjugate vaccines; Streptococcus pneumoniae.

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cardiovascular Diseases / complications*
  • Disease Progression
  • Female
  • Forced Expiratory Volume
  • Hospitalization / statistics & numerical data
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Pneumococcal Infections / prevention & control*
  • Pneumococcal Vaccines / therapeutic use*
  • Prospective Studies
  • Pulmonary Disease, Chronic Obstructive / complications*
  • Pulmonary Disease, Chronic Obstructive / physiopathology
  • Vaccination
  • Vaccines, Conjugate

Substances

  • Pneumococcal Vaccines
  • Vaccines, Conjugate